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Background: The ability to predict the long-term success of surgical treatment in orthopaedics is invaluable, particularly in clinical
trials. The quality of repair tissue formed 1 year after autologous chondrocyte implantation (ACI) in the knee was analyzed and
compared with clinical outcomes over time.
Hypothesis: Better quality repair tissue and a better appearance on magnetic resonance imaging (MRI) 1 year after ACI lead to
improved longer-term clinical outcomes.
Study Design: Cohort study; Level of evidence, 3.
Methods: Repair tissue quality was assessed using either MRI (11.5 ± 1.4 [n ¼ 91] or 39.2 ± 18.5 [n ¼ 76] months after ACI) or
histology (16.3 ± 11.0 months [n ¼ 102] after ACI). MRI scans were scored using the whole-organ magnetic resonance imaging
score (WORMS) and the magnetic resonance observation of cartilage repair tissue (MOCART) score, with additional assessments
of subchondral bonemarrow and cysts. Histology of repair tissue was performed using the Oswestry cartilage score (OsScore) and
the International Cartilage Repair Society (ICRS) II score. Clinical outcomes were assessed using the modified Lysholm score
preoperatively, at the time of MRI or biopsy, and at a mean 8.4 ± 3.7 years (maximum, 17.8 years) after ACI.
Results: At 12 months, the total MOCART score and some of its individual parameters correlated significantly with clinical out-
comes. The degree of defect fill, overall signal intensity, and surface of repair tissue at 12 months also significantly correlated with
longer-term outcomes. The presence of cysts or effusion (WORMS) significantly correlated with clinical outcomes at 12 months,
while the presence of synovial cysts/bursae preoperatively or the absence of loose bodies at 12 months correlated significantly
with long-term clinical outcomes. Thirty percent of repair tissue biopsies contained hyaline cartilage, 65% contained fibrocartilage,
and 5% contained fibrous tissue. Despite no correlation between the histological scores and clinical outcomes at the time of
biopsy, a lack of hyaline cartilage or poor basal integration was associated with increased pain; adhesions visible on MRI also
correlated with significantly better histological scores.
Conclusion: These results demonstrate that MRI at 12 months can predict longer-term clinical outcomes after ACI. Further
investigation regarding the presence of cysts, effusion, and adhesions and their relationship with histological and clinical outcomes
may yield new insights into the mechanisms of cartilage repair and potential sources of pain.
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Since its inception over 20 years ago,3 autologous chondro-
cyte implantation (ACI) has been used worldwide in the
treatment of chondral/osteochondral defects. Despite this,
there remains a need for reliable outcome measures, par-
ticularly ones capable of predicting long-term clinical out-
comes. Treatment success is often assessed with functional
questionnaires such as the modified Lysholm score.24
Magnetic resonance imaging (MRI) is commonly utilized
for the evaluation of cartilage defects and their repair, cus-
tomarily using the magnetic resonance observation of car-
tilage repair tissue (MOCART) score.14 TheMOCART score
was specifically designed for the analysis of cartilage repair
after ACI14 as an alternative to whole-knee scoring systems
designed to assess the severity and progression of osteoar-
thritis, such as the whole-organ magnetic resonance imag-
ing score (WORMS).18
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A less common, more invasive technique for determining
the quality of repair tissue is achieved by histology of a
biopsy performed during “second-look” arthroscopic sur-
gery.10 By necessity, this must be of a very small portion of
the repair tissue, allowing the evaluation of criteria such as
tissue morphology (presence/absence of hyaline cartilage)
that cannot be obtained via imaging, although parameters
such as lateral integration are more difficult to determine.
There have been conflicting reports in the literature as to
the correlation between clinical outcomes and MRI
scores,4,6,14,22 while others state little if any correlation
between clinical outcomes and histological scores.5,9,11,16
Few studies, however, have assessed the relationship
between histology and MRI.19,27,28 In addition, the scores
used for clinical outcomes, MRI, and histology vary.
In this retrospective study, we examined data from
patients who underwent ACI for chondral/osteochondral
defects of the knee, assessed the quality of repair tissue
by both imaging and histology, and compared it with clin-
ical outcomes in the short and longer term. We hypothe-
sized that better quality repair tissue at 12 months after
ACI, resembling healthy, native articular cartilage, leads to
improved midterm to long-term clinical outcomes.
METHODS
Patients and ACI Procedure
All patients (N ¼ 163) recruited to this study have been
investigated as part of an ethically approved project (REACT
09/H1203/90, granted by the West Midlands National
Research Ethics Service). Each patient underwent ACI
treatment in our center for chondral/osteochondral defects
in their knee using a 2-stage procedure as described
previously.3 Macroscopically normal cartilage was har-
vested and processed in our on-site Good Manufacturing
Practice–approved laboratory, and isolated chondrocytes
were culture-expanded in monolayer for approximately 21
days. These autologous cells were then implanted during
an open procedure beneath either a periosteal (ACI-P) or
collagen (ACI-C) (Chondro-Gide; Geistlich Pharma) mem-
brane. The location and approximate size of the treated
defect(s) were recorded on a specifically designed knee
map.26 Patient demographics are shown in Table 1. At
approximately 12 months after ACI, patients were offered
arthroscopic surgery for a repair tissue biopsy to be per-
formed, as is common practice.
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TABLE 1
Patient Demographic Dataa
Males (n ¼ 118) Females (n ¼ 45) Total (N ¼ 163)
Age at the time of ACI, y 35.7 ± 9.4 (15-70) 37.2 ± 9.9 (16-65) 36.2 ± 9.5 (15-70)
Location of defect, n
MFC 77 31 108
LFC 20 11 31
Patella 8 5 13
Trochlea 17 5 22
MTP 6 2 8
LTP 4 2 6
Total 132 56 188
Size of defect, cm2
MFC 5.4 ± 3.8 (0.3-22.5) 4.1 ± 4.3 (0.5-21.0) 5.0 ± 4.0 (0.3-22.5)
LFC 4.9 ± 3.2 (1.0-12.0) 5.3 ± 2.7 (2.0-10.8) 5.1 ± 2.9 (1.0-12.0)
Patella 4.4 ± 2.9 (0.5-9.6) 1.8 ± 0.9 (1.0-3.0) 3.5 ± 2.7 (0.5-9.6)
Trochlea 5.1 ± 3.5 (0.5-12.0) 2.8 ± 3.2 (0.5-7.5) 4.6 ± 3.5 (0.5-12.0)
MTP 2.7 ± 1.3 (1.2-4.0) 5.2 ± 3.3 (2.8-7.5) 3.4 ± 2.1 (1.2-7.5)
LTP 4.9 ± 4.9 (0.5-12.0) 2.9 ± 2.8 (0.9-5.0) 4.3 ± 4.2 (0.5-12.0)
Total 5.1 ± 3.6 (0.3-22.5) 4.1 ± 3.7 (0.5-21.0) 4.6 ± 3.5 (0.3-22.5)
Patch type,b No. of defects treated
Chondro-Gide 51 25 76
Periosteum 77 30 107
aValues are shown as mean ± SD (range) unless otherwise indicated. ACI, autologous chondrocyte implantation; LFC, lateral femoral
condyle; LTP, lateral tibial plateau; MFC, medial femoral condyle; MTP, medial tibial plateau.
bFor 5 treated defects, the patch type was unknown.
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Clinical Outcomes
Patient-reported modified Lysholm scores,24 as a measure
of knee function, were obtained at baseline, at the time of
biopsy and/or MRI, at yearly intervals after ACI, and at the
patients’ final clinical follow-up at a mean of 8.4 ± 3.7 years
(range, 2.0-17.8 years). Only those biopsies and MRI scans
with a corresponding Lysholm score (completed within
4 months of biopsy or MRI) were used to analyze any cor-
relation with clinical outcomes.
Magnetic Resonance Imaging
A total of 241 MRI scans from 136 patients (98 male,
38 female) with a corresponding Lysholm score were
included in this study. MRI was performed at a mean
1.7 ± 2.1 months before stage 1 ACI (“baseline”; range, 0-
10 months; n ¼ 74), at a mean 11.5 ± 1.4 months after ACI
(“12 months”; range, 10-16 months; n ¼ 91), and at a final
radiological follow-up of 3.3 years after ACI (mean, 39.2 ±
18.5 months; range, 16-119 months; n ¼ 76). MRI between
1998 and 2010 was performed on a 1.5-T scanner (Siemens)
with (1) a T1 sagittal and coronal spin echo sequence, (2) a
sagittal proton density with fat saturation (PD-FS)
sequence, (3) an axial dual echo with PD-FS and T2 with
fat saturation sequence, (4) a coronal short TI inversion
recovery sequence, and (5) three 3-dimensional (3D)
sequences: 3D Genzyme, T1 3D fast low-angle shot
(FLASH) water excitation, and 3D FLASH 30 flip angle.
MRI from December 2011 onward was performed on a 3-T
scanner with (1) a T1 sagittal spin echo sequence, (2) a
sagittal PD-FS sequence, (3) a coronal and axial PD-FS
sequence, (4) a T2-star sagittal sequence, and (5) the same
3D sequences as described above. The 3D images were
acquired in the sagittal plane except for patients with patel-
lar grafts, who were viewed in the axial plane.
MRI scans were scored in a blinded fashion by an expe-
rienced orthopaedic radiologist consultant (I.W.M.) special-
izing in cartilage repair, with both the WORMS18 (score of
0 [best] to 326 [worst] at baseline, 12 months, and follow-
up) and MOCART score14 (score of 0 [worst] to 100 [best] at
12 months and follow-up). The single subchondral bone
parameter of the MOCART score, which encompasses
edema, granulation tissue, cysts, and sclerosis, was
expanded to record the presence of subchondral cysts
(absent, 0; small, 1; large, 2; multiple, 3) and edema (absent,
0; mild, 1;moderate, 2; severe, 3) as individual parameters in
addition to the singleMOCART parameter and was assessed
separately. The number of osteophytes (in addition to the
WORMS size parameter) was also recorded.
Repair Tissue Biopsy
A total of 102 core biopsies (1.8-mm diameter) of repair tis-
sue formed at the site of the treated defect (using knee maps
as a guidance)26 were performed in 81 patients (82 proce-
dures; 61 male and 20 female). These were performed
arthroscopically using a juvenile bonemarrow biopsy needle
(at a mean of 16.3 ± 11.0 months [range, 4-80 months] after
ACI), snap-frozen in liquid nitrogen–cooled hexane, and
stored at –196C until cryosectioning. Cryosections 7 mm
thick were collected onto poly-L-lysine–coated slides and
stained with either hematoxylin and eosin or toluidine blue
to assess the general morphology and proteoglycan content
of repair tissue, respectively,20 and polarized light to assess
collagen fiber organization and orientation. Semiquantita-
tive scoring was performed using both the Oswestry carti-
lage score (OsScore; a nominal score of 0-10 with 7
parameters)19 and the International Cartilage Repair Soci-
ety (ICRS) II score (a visual analog scale of 0-10 for each of
the 14 parameters)13; for both scoring systems, a higher
score represents better quality of repair tissue. Only those
repair tissue biopsies with an MRI scan taken within 4
months of the biopsy were used to compare histology and
MRI.
Statistical Analysis
Data were tested for normality using the Shapiro-Wilk
test, and subsequent analyses were performed as appro-
priate. Nonparametric unpaired data were analyzed for
statistical differences using either the Mann-Whitney U
test or Kruskal-Wallis test for variance (applying the Bon-
ferroni post hoc correction). Correlations were assessed
using the Spearman rank correlation. Statistical differ-
ences between grouped frequency data of the Lysholm
score parameters were examined using the Pearson chi-
square test of independence. A P value of<.05 was deemed
significant. Linear regression analyses were used to deter-
mine the association between MRI scores and clinical out-
comes over time. Statistical analyses were performed
using Analyse-it software for Microsoft Excel (v 2.30).
RESULTS
MRI Versus Clinical Outcomes
The median baseline Lysholm score was 54 (range, 21-83)
and at 12 months had significantly improved to 71 (range,
21-100) (P < .0001). At a mean final clinical follow-up of
8.4 ± 3.7 years, the median Lysholm score had significantly
dropped to 58 (range, 17-100) (P < .012) but remained sig-
nificantly higher than at baseline (P < .035). Patient age at
ACI did not significantly correlate with clinical outcome.
Despite no significant difference in the size of ACI-C–
and ACI-P–treated defects, patients undergoing ACI-C had
significantly lower Lysholm scores preoperatively, at
12 months, and at final clinical follow-up (Figure 1). The
mean follow-up for ACI-C–treated patients was signifi-
cantly shorter than for ACI-P–treated patients (6.1 ± 2.7
vs 9.8 ± 3.7 years, respectively).
MOCART Score
At 12 months after ACI, the median MOCART score was 70
(range, 0-95) and was significantly decreased at final radio-
logical follow-up to a median of 60 (range, 0-100) (P ¼ .045).
It correlated significantly with the Lysholm score at both
12 months (r ¼ 0.32, P ¼ .0025) and at radiological follow-
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up (r ¼ 0.35, P ¼ .0032). Furthermore, 4 of the 9 scoring
parameters (degree of defect fill, surface and structure of
repair tissue, overall signal intensity) in addition to 1 of
the 2 extra parameters scored (subchondral cysts) had a
significant association with clinical outcomes (Table 2).
The use of either Chondro-Gide or periosteum did not
significantly affect MOCART scores at 12 months (median
MOCART score of 70 for both patches), but at final radio-
logical follow-up, defects treated with ACI-C had a signif-
icantly lower MOCART score (median, 39 [range, 0-95])
than those treated with ACI-P (median, 65 [range, 10-
100]) (P ¼ .012).
WORMS Value
The median WORMS value at baseline was 18 (range, 0-
74), with no significant difference at 12 months (median, 17
[range, 1-95.5]). By final radiological follow-up, the median
WORMS value had risen to 28.5 (range, 3-215), which was
significantly higher (ie, worse) than at both baseline (P ¼
.04) and 12 months (P ¼ .05). There was a significant cor-
relation with clinical outcomes observed at 12months (r¼ –
0.21, P ¼ .043) but not at baseline or radiological follow-up.
There was also a significant correlation between the
WORMS and MOCART score (r ¼ –0.46, P < .0001). No
significant difference in WORMS values was observed
between the 2 patch types at either baseline or 12 months,
but patients treated with ACI-C had significantly higher
WORMS values at final radiological follow-up (median,
58.5 [range, 3-215]) (P ¼ .015) than patients treated with
ACI-P (median, 21.2 [range, 3-73]).
There was a weak but significant correlation with clinical
outcomes at 12 months for the WORMS parameter of sub-
chondral cysts (r ¼ –0.25, P ¼ .05) (Figure 2A). Additionally,
patients with moderate/severe effusion had a significantly
lower Lysholm score than patients with either mild effusion
or none at all (Figure 2B). No other WORMS parameter or
the number of osteophytes demonstrated any significant cor-
relation with clinical outcomes at 12 months after ACI.
TABLE 2
Relationship Between MOCART Scoring Parameters
and Clinical Outcomes at 12 Months After ACIa
MOCART Parameter
MRI
Scans,
%
Lysholm Score
P
Value
Median
(Range) IQR
Degree of defect fill .002b
Complete 47 73 (21-100) 27
Hypertrophic 16 75 (33-92) 40
>50% adjacent cartilage 17 81 (46-100) 19
<50% adjacent cartilage 8 50 (33-63) 12
Exposed subchondral bone 12 42 (29-88) 34
Integration to border .064b
Complete 60 75 (25-100) 27
Incomplete 15 71 (35-100) 38
Defect <50% repair length 12 58 (21-96) 38
Defect >50% repair length 13 42 (29-88) 45
Surface of repair tissue .002b
Intact 57 75 (25-100) 25
Damage <50% repair depth 21.5 77 (21-100) 32
Damage >50% repair depth 21.5 46 (29-88) 32
Structure of repair tissue .033c
Homogeneous 55 75 (21-100) 32
Inhomogeneous 45 58 (29-100) 38
Overall signal intensity .018b
Identical to adjacent cartilage 17 71 (42-96) 26
Slight signal alteration 60 75 (21-100) 27
Large signal alteration 23 46 (29-92) 39
Subchondral lamina .744c
Intact 38 71 (21-100) 32
Not intact 62 71 (29-100) 33
Subchondral bone .485c
Intact 33 75 (33-100) 33
Not intact 67 71 (21-100) 33
Adhesions .428c
Absent 76 71 (21-100) 30
Present 24 67 (33-92) 42
Effusion .246c
Absent 59 75 (25-100) 29
Present 41 58 (21-100) 38
Subchondral cystsd .049b
Absent 75 75 (21-100) 33
Small 20 63 (29-92) 35
Large/multiple 4 40 (33-63) 19
Subchondral marrow edemad .655b
Absent 37 73 (33-100) 34
Mild 46 71 (21-96) 33
Moderate/severe 17 60 (29-100) 42
aBolded P values indicate statistically significant association
between MOCART parameter and Lysholm score. ACI, autologous
chondrocyte implantation; IQR, interquartile range; MOCART,
magnetic resonance observation of cartilage repair tissue; MRI,
magnetic resonance imaging.
bKruskal-Wallis 1-way analysis of variance (with post hoc Bon-
ferroni) of MOCART parameter versus Lysholm score.
cMann-Whitney U test of MOCART parameter versus Lysholm
score.
dAdded to standard MOCART parameters.
Figure 1. Patients treated with collagen autologous chondro-
cyte implantation (ACI-C) had significantly lower Lysholm
scores than patients treated with periosteal autologous chon-
drocyte implantation (ACI-P) at each of the 3 time points. The
box and the horizontal line represent the interquartile range
and the median, respectively, and the whiskers represent the
range. FU, follow-up.
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To assess if MRI could predict long-term clinical out-
comes, WORMS and MOCART scores at 12 months were
compared with long-term clinical follow-up Lysholm scores.
While the totalMOCART score at 12months demonstrated a
positive correlation with long-term clinical follow-up scores,
it was not significant (r¼ 0.20,P¼ .13). However, individual
parameters of the degree of defect fill (P ¼ .02), surface of
repair tissue (P ¼ .02), and overall signal intensity (P ¼ .04)
at 12 months all demonstrated a positive significant rela-
tionship with final clinical follow-up scores.
For theWORMS, the presence of synovial cysts/bursae at
baseline was related to significantly better clinical out-
comes at follow-up than in their absence (P ¼ .007). The
absence of loose bodies at 12 months (r ¼ 0.20, P ¼ .04) was
also associated with significantly better clinical outcomes
at follow-up than when present.
Male Versus Female Sex
The age at ACI was not found to be significantly different
between male and female patients. Female patients had a
significantly lower median baseline Lysholm score of 36
compared with 49 in male patients (P ¼ .05). At 12 months,
however, both male and female patients had a significant
increase in the median Lysholm score to 71 (P < .0001).
Both sexes also had a drop in the median Lysholm score
at radiological follow-up to 63 (male) and 50 (female),
although this was not significant.
Male but not female patients had a significant decrease
in the MOCART score at radiological follow-up compared
with 12 months (Figure 3A), with no significant difference
in MOCART scores between the sexes at either 12 months
or radiological follow-up. Male patients also demonstrated
Figure 3. Sex-based differences in magnetic resonance imaging outcomes. (A) Magnetic resonance observation of cartilage repair
tissue (MOCART) scores were significantly lower at final radiological follow-up compared with 12 months for male patients but not
female patients. (B) Whole-organ magnetic resonance imaging score (WORMS) values were also significantly increased at radio-
logical follow-up for male patients compared with baseline and 12 months but not for female patients. Male patients had signif-
icantly higher WORMS values at final radiological follow-up than female patients. The box and the horizontal line represent
the interquartile range (IQR) and the median, respectively, and the whiskers represent the range. þ Outliers >1 and <3 IQR. FU,
follow-up.
Figure 2. Whole-organ magnetic resonance imaging score (WORMS) values for (A) subchondral cysts and (B) effusion demon-
strated a significant relationship with clinical outcomes at 12 months after autologous chondrocyte implantation. The box and the
horizontal line represent the interquartile range (IQR) and the median, respectively, and the whiskers represent the range. þOutliers
>1 and <3 IQR.
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a significant negative correlation of MOCART scores over
time (r ¼ –0.18, P ¼ .045).
The WORMS value demonstrated a significant correla-
tion with time after ACI in male patients (r ¼ 0.28,
P ¼ .001) but not female patients. Male patients also had
a significantly higher WORMS value at final radiological
follow-up than at both baseline and 12 months (Figure 3B).
There was no significant difference in WORMS values in
female patients between the 3 time points. Male patients
had a significantly higher WORMS value than female
patients at final radiological follow-up but not at baseline
or 12 months. The significant correlation between WORMS
andMOCART scores was not affected by sex, withmale and
female patients both demonstrating a significant correla-
tion between WORMS and MOCART scores (r ¼ –0.46,
P < .0001 and r ¼ –0.44, P ¼ .01, respectively).
Histology Versus Clinical Outcomes
Of the 102 biopsies analyzed, the mean OsScore value was
6.3 ± 1.6 (range, 1.3-9.5), and the mean total ICRS II score
was 87.4 ± 16.5 (range, 36.7-126.6), with no significant dif-
ference betweenmale and female patients for either scoring
system. Despite only 11.8% of biopsies being predominantly
hyaline cartilage, the majority of biopsies demonstrated
good or excellent matrix metachromasia, surface architec-
ture, and basal integration, with few observations of ectopic
calcification or vascularization (Table 3). ICRS II scores
also demonstrated a high degree of variability across all
parameters in the biopsies analyzed (Table 4). The median
ICRS II tissue morphology score was 5.7 (0 being fibrous
tissue, 10 being perfect hyaline cartilage), reflecting the
high proportion of fibrocartilage biopsies, also demon-
strated by the OsScore. Additionally, the median score for
basal integration was 8.7 (0 as worst, 10 as best), also
reflecting the OsScore. The median score for tidemark for-
mation was poor at 2.1, but scores ranged from 0.0 to 9.8,
again reflecting the heterogeneous nature of the repair tis-
sue biopsies.
When comparing the OsScore parameters with Lysholm
scores, no patients whose biopsies consisted solely of hya-
line cartilage complained of constant pain. In contrast, all
patients whose biopsies were fibrous tissue complained of
some degree of pain, and 50% of patients complaining of
constant pain had poor basal integration. All patients with
vascularization present in repair tissue complained of some
degree of pain, while all patients with fibrous tissue or vas-
cularization had some degree of limp. There was not, how-
ever, any significant correlation or association with any of
the histological parameters assessed by either scoring sys-
tem in relation to clinical outcomes at 12 months (Tables 3
and 4) or at final clinical follow-up (mean, 8.5 ± 3.6 years
[range, 2.1-16.4 years]).
MRI Versus Histology
There were 54 patients (55 procedures) who underwent
both a biopsy and an MRI within 4 months of each other,
resulting in a total of 59 biopsies and 56MRI scans. For this
subgroup, the mean time of biopsy was 13.3 ± 5.6 months
(range, 8-40 months), and the mean time of MRI was 12.7 ±
6.6 months (range, 6-42 months). Overall, there was no
significant correlation between the total OsScore or ICRS
II score with the overall MOCART score or WORMS.
A negative trend was observed between the ICRS II sub-
chondral bone and tidemark parameters and the MOCART
parameters of degree of defect fill and signal intensity,
respectively. There was also a significant negative correla-
tion between the number of osteophytes present in the joint
and the tidemark score of repair tissue (r¼ –0.26, P¼ .042).
Interestingly, the presence of adhesions on MRI, observed
in 10 of 54 patients, correlated with significantly better
tissue morphology, significantly better tidemark formation,
and significantly better cell morphology (Figure 4, A-F).
Although not quite reaching significance, the presence of
adhesions also correlated with a higher overall ICRS II
score but worse surface architecture and more chondrocyte
TABLE 3
Association of Clinical Outcomes With OsScore
Scoring Parameters at 12 Months After ACIa
OsScore Parameter
Biopsies,
%
Median Lysholm
Score P Value
Tissue morphology .479b
Hyaline 11.8 63
Hyaline/fibrocartilage 18.6 53
Fibrocartilage 64.7 74
Fibrous tissue 4.9 62
Matrix metachromasia .615b
Normal 46.0 74
Moderate 41.0 68
Abnormal 13.0 62
Clusters .707b
None 54.9 69
25% total cell number 36.3 70
>25% total cell number 8.8 53
Surface .335b
Near normal 19.0 62
Moderately irregular 42.9 63
Irregular 38.1 75
Basal integration .314b
Good 63.6 65
Moderately irregular 31.8 75
Poor 4.5 39
Calcification .605c
Absent 68.6 63
Present 31.4 75
Vascularization .102c
Absent 93.1 70
Present 6.9 40
Total N/A N/A .745d
aACI, autologous chondrocyte implantation; N/A, not applica-
ble; OsScore, Oswestry cartilage score.
bKruskal-Wallis 1-way analysis of variance (with post hoc Bon-
ferroni) of OsScore parameter versus Lysholm score.
cMann-Whitney U test of OsScore parameter versus Lysholm
score.
dP value after Spearman rank correlation of total OsScore value
versus Lysholm score.
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clusters (Figure 4, G-I). Furthermore, those patients with
adhesions present had a significantly lower overall
MOCART score (median, 20 [range, 0-80]) (P ¼ .0001) than
those without (median, 75 [range, 10-95]). Likewise, the
WORMS value was also significantly higher in the presence
of adhesions (median, 40 [range, 4-115.5]) (P ¼ .015) com-
pared with no adhesions (median, 14 [range, 3-105.5]). Nei-
ther the structure of repair tissue (on MRI) nor the overall
signal intensity had any correlation with the tissue mor-
phology of the biopsies assessed histologically.
The presence of hyaline cartilage to any extent in repair
tissue did not show a significant relationship with the over-
all MOCART score compared with repair biopsies contain-
ing only fibrocartilage. Only 2 biopsies in this subgroup (ie,
with an MRI scan at a similar time point) were categorized
as fibrous tissue, and these had an overall MOCART score
of 80 and 25. Neither of these biopsies had poor basal inte-
gration. The overall MOCART score did not significantly
correlate with either the presence or severity of ectopic cal-
cification or vascularization, as seen histologically.
DISCUSSION
The ability to detect, measure, and assess the success of
cartilage repair in a minimally invasive manner has great
appeal to both the clinician and particularly the patient. If
this can be performed at a relatively early stage and can
predict the likely long-term success, it will be beneficial for
clinical trials, especially in slowly developing conditions
such as osteoarthritis after a cartilage injury. Imaging
modalities such as MRI have considerable capability, but
despite having been used as a diagnostic tool for many
years, its accuracy and value in assessing clinical
outcomes in patients after treatment have remained
under scrutiny. Meta-analyses and systematic reviews
have demonstrated wide variability in the choice of clini-
cal outcome measures used for assessing the relationship
between MRI and clinical outcomes.2,4 The majority of
studies have focused solely on the region of repair carti-
lage and not the whole joint. In this study, we have utilized
2 different MRI scoring systems to determine the impact
and efficacy of autologous cell therapy in relation to both
clinical outcomes and histology. To that effect, we have
demonstrated the ability of MRI at 12 months after ACI
to predict clinical outcomes at a mean of 8.4 years after
treatment. This current study enhances our previous
findings19,27 with the inclusion of greater numbers of
patients, their repair tissue biopsies and MRI scans, the
addition of an analysis of the correlation to clinical out-
comes, and more in-depth histological and radiological
scoring systems.
The results presented in this study demonstrate a signif-
icant positive correlation at 12 months between the
MOCART score and clinical outcomes after ACI for the
treatment of chondral/osteochondral defects. In addition,
these results indicate that the assessment of features such
as the degree of defect fill, surface of repair tissue, and
overall signal intensity by MRI can be used to predict
long-term clinical outcomes. Repair tissue with a smooth
surface, well integrated with surrounding native cartilage,
is necessary for maintaining a functional, intact joint sur-
face. Likewise, a homogeneous structure of repair visible on
MRI is indicative of healthy cartilage, with typical cartilage
layers formed within repair tissue free of fissures and
clefts.15
The MOCART score is one of the most commonly used
scoring systems for the MRI assessment of cartilage repair.
As with most scoring systems, the MOCART score has also
been subject to “improvement”; the original score has been
superseded by a modified 3D MOCART score,29 with the
categories within the original (2-dimensional) MOCART
score having been expanded on (such as degree of defect fill
and effusion) or combined (such as surface and adhesions),
or having new ones added altogether (such as bone inter-
face and chondral osteophytes). As the majority of the MRI
scans analyzed in this particular study were historical and
stretched back almost 20 years to when more simple MRI
sequences were taken, the 3D MOCART score was unfor-
tunately not possible to use in many of our analyses. How-
ever, because the MOCART score is restricted to assessing
repair cartilage only and the patients’ clinical well-being is
likely be affected by more than just this, we also used the
WORMS to assess the status of the whole joint.
The WORMS was developed as a multifeature evaluation
of the knee, designed for use in osteoarthritis.18 Although
cumbersome in its analysis of 14 parameters across a total
of 14 regions, the scoring system has demonstrated good
interobserver agreement by both its creators and our group
(unpublished data). A modified WORMS has since been
developed,25 reducing the number of anatomic regions to only
6, by assessing areas such as the medial and lateral condyles
and the tibial plateau as whole entities and not examining
anterior, posterior, and central regions individually. We
TABLE 4
Association of Clinical Outcomes With ICRS II
Scoring Parameters at 12 Months After ACIa
ICRS II Score
ICRS II Parameter Median (Range) IQR Pb
Tissue morphology 5.7 (0.7-9.8) 1.7 .427
Matrix metachromasia 7.0 (0.6-9.9) 3.3 .357
Cell morphology 4.4 (0.0-9.9) 5.1 .999
Chondrocyte clusters 9.9 (0.2-10.0) 1.9 .543
Surface architecture 5.5 (0.5-10.0) 4.1 .377
Basal integration 8.7 (0.6-10.0) 3.3 .809
Tidemarks 2.1 (0.0-9.8) 3.8 .749
Subchondral bone abnormalities 7.8 (1.5-9.9) 2.2 .228
Inflammation 10.0 (8.1-10.0) 0.0 .224
Calcification 10.0 (0.4-10.0) 1.5 .590
Vascularization 10.0 (0.7-10.0) 0.0 .103
Surface/superficial assessment 4.9 (0.3-9.3) 2.5 .491
Middle/deep assessment 5.3 (0.6-9.6) 2.2 .851
Overall assessment 4.9 (0.6-9.5) 2.5 .835
aACI, autologous chondrocyte implantation; ICRS, Interna-
tional Cartilage Repair Society; IQR, interquartile range.
bP value after Spearman rank correlation of ICRS II parameter
versus clinical outcome.
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Figure 4. The relationship between the presence of adhesions identified by magnetic resonance imaging (MRI) and histology. (A, B)
Visible adhesions observed on consecutive slices of an MRI scan (white arrows) demonstrated a significant relationship with (C,
representative hematoxylin and eosin–stained biopsy) repair tissue and International Cartilage Repair Society (ICRS) II histological
scores for (D) tissue morphology, (E) presence of tidemarks, and (F) cell morphology. Noticeable trends were also observed for (G)
the overall ICRS II score, (H) surface architecture, and (I) chondrocyte clusters. Biopsy performed on a 44-year-old male patient of
the treated defect 12 months after autologous chondrocyte implantation; the corresponding MOCART and WORMS values for this
patient were 5 and 54.5, respectively. The box and the horizontal line represent the interquartile range (IQR) and the median,
respectively, and the whiskers represent the range. þ Outliers >1 and <3 IQR.
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chose, however, to adhere to the original parameters to allow
for a more in-depth examination of the joint, with the excep-
tion of the “S” region, which was not scored in this study.
Despite the fact that the WORMS and MOCART were
designed for different applications, some parameters over-
lap between the 2 scoring systems, for which we observed
similarities in the results between the scores and their cor-
relation with clinical outcomes. For example, both scoring
systems demonstrated a reduction in the Lysholm score at
12 months after ACI when there was effusion present,
although this was only statistically significant for the
WORMS. This may be because the WORMS categorizes the
level of effusion across the whole joint rather than simply
questioning its presence or absence, as in the more restric-
tive repair-only region assessed by the MOCART score.
Both scoring systems also demonstrated a significant cor-
relation between the presence and severity of subchondral
cysts and a reduction in clinical outcomes. Taken together,
this suggests that effusion and subchondral cysts are asso-
ciated with pain and other debilitating symptoms, in keep-
ing with other studies.6,23 Thus, future research may
benefit from the additional use of questionnaires that
assess pain alongside physical function in more detail, such
as the Western Ontario and McMaster Universities Osteo-
arthritis Index (WOMAC), when assessing clinical out-
comes,1 particularly as sources of pain within such joints
are unknown. The finding of the presence of synovial cysts/
bursae at baseline correlating with significantly better
Lysholm scores at clinical follow-up is interesting. It is pos-
sible that the implanted cells affected these tissues also; it
is likely that some of the implanted chondrocytes were pro-
genitor cells and so could have similar properties to mesen-
chymal stem cells, which are known to have paracrine
influences possibly including anti-inflammatory effects.
Second-look arthroscopic surgery is still considered an
important procedure for assessing the success of cartilage
repair techniques,10 although it is not undertaken in
all studies. However, we found little or no significant cor-
relation between the histological assessment of repair
tissue and clinical outcomes, as previously reported by
others,5,11,16 which raises questions about the predictive
usefulness of histology. Despite this, we have demonstrated
some interesting relationships between the Lysholm
score parameters of pain and limping with histological
parameters of repair tissue morphology, basal integration,
and vascularization. While the ability to microscopically
assess repair tissue is invaluable for learning more about
the biology of repair processes involved, it is important to
remember that a repair tissue biopsy only enables the eval-
uation of repair at a single point of location and time in
potentially actively remodeling tissue. Therefore, pinpoint-
ing any particular histological feature(s) apparently asso-
ciated with pain levels could prove challenging.
Significant correlations between histology and MRI have
previously been identified for clinical indications such as
prostate cancer, epilepsy, and amyotrophic lateral
sclerosis.7,12,17 We have seen a few significant correlations
between histology and MRI in our study but not many,
perhaps reflecting the different and often complementary
types of information provided by the 2 modalities. For
example, we have previously demonstrated that the use of
ACI-C results in significantly superior quality of repair tis-
sue when assessed histologically,16 but such findings were
not reflected in the present study when assessed by MRI;
the 2 patch types were not significantly different at 12
months. The significantly inferior quality of repair tissue
(as assessed by MRI) after ACI-C compared with ACI-P
seen in this study, however, demonstrates the importance
of longitudinal follow-up and the location- and time-
dependent nature of histological assessments.
We have shown an interesting correlation between the
presence of adhesions identified on MRI and significantly
better histological features in repair tissue. Adhesions are
common after knee surgery8 and are associated with knee
stiffness and arthrofibrosis, and thus, their correlation with
significantly better histological scores is surprising. Despite
this, we did not observe a significant relationship between
the presence of adhesions and clinical outcomes. Adhesions
are difficult to diagnose on MRI, and the severity of adhe-
sions rather than their presence alonemay be important in
detecting a significant relationship with clinical outcomes.
Could these “adhesions” perhaps be processes of other tis-
sues (such as synovium) that are actually aiding in the
repair or growth of the tissue?21 Future studies regarding
the cause of adhesions, their role in tissue regeneration,
and their relationship with cartilage morphology could
indicate the mechanisms of repair not yet realized.
This study has some limitations. One of these is that it is
a retrospective study of routinely treated patients; data
were therefore not collected as systematically or at matched
time points, for example, as they might have been in a
clinical trial. Additionally, there was a wide range of dis-
ease severity within the treated joints, thus making com-
parisons more difficult—another factor that could be better
controlled in a clinical trial. A further limitation of the
study could be the wide age range of patients treated, up
to the age of 70 years, reflecting the type of patients who
typically present to clinics in a secondary or tertiary refer-
ral orthopaedic center such as ours. We found no significant
effect of age on clinical outcomes; in fact, the 2 oldest
patients in the study, aged 65 and 70 years, had Lysholm
scores of 92 and 100 after 8 and 7 years’ follow-up, respec-
tively. Only 1 radiologist scored the MRI scans, which could
be considered a limitation. However, this radiologist was
extremely experienced, in addition to which the interclass
correlations with another radiologist for the MOCART and
WORMS scores were 0.55 and 0.92, respectively.
CONCLUSION
These results are encouraging in showing a significant
association between the MOCART score and some of its
individual parameters with both short-term and longer-
term clinical outcomes in ACI-treated patients. This high-
lights the potential for MRI at 1 year to predict long-term
clinical outcomes after cartilage repair, such as may be use-
ful in clinical trials. Whereas the MOCART score assesses
the complete graft, histology only examines a small, dis-
crete region and cannot assess parameters such as lateral
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integration, hypertrophy, and subchondral cysts. Combin-
ing MRI with histology allows a more complete assessment
of repair tissue. Further investigation regarding the pres-
ence of cysts, effusion, and adhesions as identified on MRI
and their relationship with both histological and clinical
outcomes may yield new insights into the mechanisms of
cartilage repair and provide information to further under-
stand pain-generating mechanisms not only in knees with
focal cartilage defects but also in osteoarthritis.
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